Handelsbanken Fonder’s Arcus Biosciences RCUS Stock Holding History

Handelsbanken Fonder’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Buy	+39,000	New	+$964K	﹤0.01%	1048
2025 Q2	–	Sell	-24,800	Closed	-$195K	–	1561
2025 Q1	$195K	Hold	24,800	–	–	﹤0.01%	1495
2024 Q4	$369K	Buy	24,800 +2,500	+11%	+$40.8K	﹤0.01%	1401
2024 Q3	$341K	Buy	22,300 +3,000	+16%	+$47.3K	﹤0.01%	1380
2024 Q2	$294K	Buy	19,300 +6,500	+51%	+$105K	﹤0.01%	1395
2024 Q1	$242K	Hold	12,800	–	–	﹤0.01%	1451
2023 Q4	$244K	Buy	+12,800	New	+$205K	﹤0.01%	1464
2022 Q4	–	Sell	-8,500	Closed	-$222K	–	1599
2022 Q3	$222K	Hold	8,500	–	–	﹤0.01%	1402
2022 Q2	$215K	Hold	8,500	–	–	﹤0.01%	1477
2022 Q1	$268K	Sell	8,500 -3,800	-31%	-$127K	﹤0.01%	1561
2021 Q4	$498K	Hold	12,300	–	–	﹤0.01%	1347
2021 Q3	$429K	Hold	12,300	–	–	﹤0.01%	1443
2021 Q2	$338K	Buy	+12,300	New	+$351K	﹤0.01%	1591

Other funds holding RCUS

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Handelsbanken Fonder's RCUS Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 39,000 shares worth $1.2M. The stake represents ﹤0.01% of the portfolio and ranks #1048 among its holdings. This is a return to the name: Handelsbanken Fonder previously reported a position in RCUS as recently as Q1 2025.

Handelsbanken Fonder first reported a position in RCUS in Q2 2021 and has held it in 13 quarters since. 17 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

Handelsbanken Fonder held 39,000 shares of Arcus Biosciences worth $1.2M as of Q2 2026.
Arcus Biosciences was a new Handelsbanken Fonder position in Q2 2026.
Arcus Biosciences made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1048 holding.
Handelsbanken Fonder first reported a position in Arcus Biosciences in Q2 2021 and has held it in 13 quarters since.
17 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.